Recall · openFDA Food Enforcement

Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets: FDA Recall F-1578-2017

Agency action: Feb 13, 2017Record ID: F-1578-2017
View official source ↗

What happened

Original notice title

Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets, recall F-1578-2017

From the archived source record

Nu Skin announces a voluntary field action for Pharmanex BioGinkgo due to undeclared allergen; wheat.

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Terminated
FDA recall classification
Class II
Recall initiated by
Voluntary: Firm initiated
Report date
Mar 15, 2017
Termination date in the archive
Aug 22, 2017
Source checked
Jul 16, 2026
Record revision
f65e8fb37910

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Pharmanex BioGinkgo. Mental Sharpness. 60 Tablets
Company
Nu Skin Enterprises Inc.
Lot / identifier
Batches: DL14951-07, DL31551-07, DL21161-07
Market / distribution
Nationwide, Canadian and other foreign consignees. No VA/govt/military consignees.